The global diabetic nephropathy market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the ...

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...

Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no.) ...

We are currently confronted with an epidemic of renal failure caused by diabetic nephropathy. It has become apparent that blood pressure is a major determinant of the risk of developing diabetic ...

China: A recent retrospective cohort study published in Diabetes, Metabolic Syndrome and Obesity has revealed a significant U ...

2025年6月7日，第62届欧洲肾脏协会年会（ERA）在奥地利维也纳圆满落幕。作为全球肾脏病学领域顶尖的学术盛会，本次会议汇聚了众多国际知名专家，并展示了多项前沿突破与创新实践成果。我国肾脏病学者共有90余篇研究摘要入选本届大会，研究内容涵盖肾脏病学 ...

Morphic Therapeutic Inc. has identified compounds acting as integrin αvβ1 antagonists reported to be useful for the treatment of cancer, chronic kidney disease, diabetic nephropathy, pulmonary ...

However, here’s the tricky part: as people get older, kidney function naturally slows down. This means a lower GFR might not always be a sign of disease—it could just be a part of aging. This makes it ...

China: A recent study published in Reviews in Cardiovascular Medicine highlights the significance of left atrial structural ...

Type 2 diabetes isn’t just a condition, it’s a long-term health risk. Timely testing, accurate readings, and consistent ...

For some people living with diabetes, blood sugars can drop or rise overnight and interrupt sleep. Difficulty sleeping can also affect your insulin. But there are things you can do to manage blood ...